Xeris Pharmaceuticals Reports Second Quarter 2021 Financial Results and Recent Highlights

Go back to Xeris Pharmaceuticals Reports Second Quarter 2021 Financial Results and Recent Highlights
(NASDAQ: XERS) Delayed: 8.16 +0.38 (4.88%)
Previous Close $7.78    52 Week High
Open $7.68    52 Week Low
Day High $8.18    P/E N/A 
Day Low $7.69    EPS
Volume 2,341,272